Insider Cluster ·Filed Mar 23, 2026
Insider cluster: 2 insiders, $1.1M total
Actionable Insight ◆ Mixed
Monitor for follow-up filings to determine if the CEO's purchase signals confidence amid broader insider selling. Consider the divergence between executive and other insider behavior as a potential sentiment signal.
Final — all horizons settled through T+60d
IMNM ▼ -10.70% at T+60d
NEUTRAL call ✗ call lost -10.70% · α vs SPY -23.76% · entry $20.75 → $18.53
T+1d
-2.60%
call -2.60% · α -2.25%
$20.21
settled 6mo ago
T+5d
-6.99%
call -6.99% · α -3.42%
$19.30
settled 6mo ago
T+20d
+12.14%
call +12.14% · α +4.72%
$23.27
settled 6mo ago
T+60d
-10.70%
call -10.70% · α -23.76%
$18.53
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. Recent insider activity shows CEO Clay Siegall purchased $500,601.5 worth of shares in an open-market transaction, contrasting with prior selling activity by other insiders.
Key Financial Metrics
Direction
mixed
Key Facts
- Filing is an insider trading cluster (CLUSTER) for Immunome Inc. (IMNM).
- Document content unavailable; analysis based on metadata and cross-filing context.
- CEO Clay Siegall purchased $500,601.5 in shares over the past 7 days.
- Other insiders sold $1.3M in shares over the past 30 days, while total buys amounted to $544K.
Financial Impact
$500,601.5 purchase by CEO, offset by $1.3M in recent insider sales
insider ownershipmarket sentiment
Risk Factors
- Limited visibility due to unavailable filing content.
- Mixed signals from insider activity: CEO buying while others have been net sellers.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
Report based on filing metadata.
13 reports for IMNM
100% Hit rate best @ T+60▲ +26.53%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 1d ago | ANALYST-UPGRADE | $21.58 awaiting T+5 | awaiting T+5 | — | $20.97 (−2.85%) |
Sep 21, 2026 11d ago | ANALYST-UPGRADE | $25.07 $21.68 | ▼ −13.52% | ▼ −13.24% | $20.97 (−16.37%) |
Aug 12, 2026 7w ago | Insider Cluster | $26.42 $28.08 | ▲ +6.28% | ▲ +8.25% | $20.97 (−20.65%) |
Aug 10, 2026 7w ago | Insider Cluster | $26.25 $27.56 | ▲ +4.99% | ▲ +5.39% | $20.97 (−20.13%) |
Jul 9, 2026 12w ago | Insider Cluster | $23.35 $22.20 | ▼ −4.93% | ▼ −4.36% | $20.97 (−10.21%) |
Jul 7, 2026 12w ago | Insider Cluster | $24.01 $22.59 | ▼ −5.91% | ▼ −6.78% | $20.97 (−12.68%) |
Jul 7, 2026 12w ago | Insider Cluster | $24.01 $22.59 | ▼ −5.91% | ▼ −6.78% | $20.97 (−12.68%) |
Jul 3, 2026 13w ago | Insider Cluster | $23.61 $24.17 | ▼ −2.37% | ▼ −1.44% | $20.97 (+11.20%) |
May 28, 2026 18w ago | ANALYST-UPGRADE | $22.54 $19.81 | ▼ −12.11% | ▼ −12.06% | $20.97 (−6.99%) |
May 12, 2026 20w ago | 8-K | $22.20 $19.66 | ▼ −11.44% | ▼ −10.28% | $20.97 (−5.56%) |
Showing 10 of 13
US Market Status
Market Open — Closes in 52m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access